Clinical Trial Update: Boceprevir With Peginterferon Alfa-2b and Ribavirin in the Treatment-naive Patients Infected With Genotype 4 Chronic Hepatitis C Infection [Phase 3]

View source ↗

Summary

Phase 3 trial update examining Boceprevir co-administered with peginterferon alfa-2b and ribavirin in treatment-naive patients with Genotype 4 chronic hepatitis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Boceprevir (boceprevir)
• Peginterferon alfa-2b (Peginterferon alfa-2b)
• Ribavirin (ribavirin)

Snippet

Sponsor: Theodor Bilharz Research Institute | Conditions: Genotype 4 Chronic Hepatitis C Infection | Phase 3 | Status: UNKNOWN